Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-emptive prednisolone therapy for acute graft-versus-host disease guided by proteomic patterns after allogeneic HSCT
2008-005862-30Phase 2Completed
- Sponsor
- Medizinische Hochschule Hannover
- Start
- Dec 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Acute Graft-Versus-Host Disease (aGvHD) and graft-versus-host disease (GVHD) comparing Pre-emptive prednisolone with Placebo (2 arms). Primary endpoint: Primary study endpoint. Started Dec 2008; status: completed.
02
Drugs
prednisolone
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on 2008-005862-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005862-30.